Volume 23, Issue 4 - Post-Approval Regulatory Writing

The EMWA Budapest Working Group: A 2-year collaboration to make recommendations for aligning the ICH E3 guideline with current practice and developing clinical study protocol guidance

Authors: Sam Hamilton, Walther Seiler, Art Gertel

Abstract

Download the full article

References

1. Krleža-Jeriç K. International dialogue on the public reporting of clinical trial outcome and results – PROCTOR meeting. Croat Med J 2008;49:267–8.
2. Ghersi D, Clarke M, Berlin J, Gülmezoglu AM, Kush R, Lumbiganon P, et al. Reporting the findings of clinical trials: a discussion paper. Bull World Health Organ 2008;86(6):492–3.
3. Krleža-Jeriç K, Lemmens T, Reveiz L, Cuervo LG, Bero LA. Prospective registration and results disclosure of clinical trials in the Americas: a roadmap toward transparency. Rev Panam Salud Publica 2011;30(1):87–96.
4. Prasad SM, Bennett CL. Finishing the picture: problems with public reporting of clinical trials. JCO 2013:31(24):2981–2.
5. Rawal B, Deane BR. Clinical trial transparency: an assessment of the disclosure of results of company-sponsored trials associated with new medicines approved recently in Europe. CMRO 2014:30(3):395–405.
6. Publication and access to clinical-trial data. London: European Medicines Agency. Policy 0700. Adopted 2 October 2014, effective 1 January 2015 [cited 2014 Oct 6]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Other/2014/10/WC500174796.pdf
7. ICH Harmonised Tripartite Guideline: Guideline for Good Clinical Practice E6 (R1). Step 4, 10 June 1996 [cited 2014 Jul 4]. Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6_R1/Step4/E6_R1__Guideline.pdf
8. Chan A-W, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, et al. SPIRIT 2013 Statement: defining standard protocol items for clinical trials. Ann Intern Med 2013;158:200–7.
9. Regulation (EU) no. 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use [cited 2014 Sep 24]. Available from: http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32014R0536&from=EN10
10. ICH Harmonised Tripartite Guideline: Structure and Content of Clinical Study Reports E3. Step 4, 30 November 1995 [cited 2014 Jul 4]. Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E3/E3_Guideline.pdf
11. CHMP Note for Guidance on the Inclusion of Appendices to Clinical Study Reports in Marketing Authorisation Applications. CHMP/EWP/2998/03/Final 23 June 2004 [cited 2014 Jul 4]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003638.pdf
12. ICH E3 Guideline: Structure and Content of Clinical Study Reports Questions & Answers (R1) 6 July 2012 [cited 2014 Jul 4]. Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E3/E3_QAs_R1_Step4.pdf
13. Hamilton S. Effective authoring of clinical study reports: a companion guide. MEW 2014;23(2):86–92. [cited 2014 Jul 4]. Available from: http://www.samhamiltonmwservices.co.uk/wp-content/uploads/2014/05/HamiltonS_MEW2014_232-CSRCompanionGuide.pdf
14. Joint EFPIA-PhRMA principles for responsible clinical trial data sharing. Our commitment to patients and researchers. 01 January 2014. [cited 2014 Sep 4]. Available from: http://transparency.efpia.eu/uploads/Modules/Documents/data-sharing-prin-final.pdf
15. Newby F (moderator). CDISC standards in the regulatory submission process. What's new and what's ahead. 26 January 2012. [cited 2014 Jul 4]. Available from: http://www.cdisc.org/system/files/all/event/application/pdf/cdisc_standards_in_fda_submissions_2012_01_26pdf.pdf
16. Opinion 05/2014 on anonimisation techniques, adopted 10 April 2014 by the Article 29 Data Protection Working Party [cited 2014 Oct 3]. Available from: http://www.cnpd.public.lu/fr/publications/groupe-art29/wp216_en.pdf